| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.18 | 0.3 |